We use your email only to reply to you.
Has led investments in CG Oncology (NASDAQ: CGON, Jan 2024 IPO), Chinook (acquired by Novartis), Cymabay (acquired by Gilead), Inhibrx (acquired by Sanofi), and Madrigal (NASDAQ: MDGL).
TCG Crossover